Drug intelligence / Profile preview

annona cherimola extract

Development stage
Preclinical
Lead developer
CLR Berlin
Administration
Oral
01

Overview

Annona cherimola extract is a botanical research compound derived from the seeds and other parts of the *Annona cherimola* Mill. plant, commonly known as cherimoya. The extract is characterized by its content of bioactive Annonaceous acetogenins (ACGs), which are potent secondary metabolites known to inhibit mitochondrial complex I. Preclinical studies have demonstrated that the extract possesses significant anti-cancer properties, particularly against acute myeloid leukemia (AML) and head and neck cancer cell lines. Its mechanism of action involves the induction of apoptosis through both intrinsic and extrinsic pathways, often associated with the upregulation of pro-apoptotic proteins such as BAX. Despite its potential therapeutic efficacy, the extract's development is constrained by reports of neurotoxicity and genotoxicity linked to its acetogenin components. It is currently a subject of academic investigation and is not an approved pharmaceutical product.

Other names
cherimoya extractAnnona cherimola Mill. extract
02

Targets

CASP3 (Caspase-3)BAX (Apoptosis regulator BAX)CASP9 (Caspase-9)CASP8 (Caspase-8)

Beyond the preview

Go deeper on annona cherimola extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on annona cherimola extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call